{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:49:16Z","timestamp":1785235756678,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01536-8","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T23:02:42Z","timestamp":1723935762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic and immune infiltration implications of SIGLEC9 in SKCM"],"prefix":"10.1186","volume":"19","author":[{"given":"Peipei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xieping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"issue":"1","key":"1536_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/s41467-023-36979-y","volume":"14","author":"SY Lim","year":"2023","unstructured":"Lim SY, et al. The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma. Nat Commun. 2023;14(1):1516.","journal-title":"Nat Commun"},{"issue":"3","key":"1536_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jaad.2021.09.075","volume":"86","author":"L Skudalski","year":"2022","unstructured":"Skudalski L, et al. Melanoma an update on systemic therapies. J Am Acad Dermatol. 2022;86(3):515\u201324.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"1536_CR3","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-21-3145","volume":"28","author":"J Li","year":"2022","unstructured":"Li J, et al. Single cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy. Clin Cancer Res. 2022;28(10):2131\u201346.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1536_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14(8):463\u201382.","journal-title":"Nat Rev Clin Oncol"},{"key":"1536_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102499","volume":"113","author":"DC Ziogas","year":"2023","unstructured":"Ziogas DC, et al. Mechanisms of resistance to immune checkpoint inhibitors in melanoma: what we have to overcome? Cancer Treat Rev. 2023;113: 102499.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"1536_CR6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/jso.26229","volume":"123","author":"AY Lee","year":"2021","unstructured":"Lee AY, Brady MS. Neoadjuvant immunotherapy for melanoma. J Surg Oncol. 2021;123(3):782\u20138.","journal-title":"J Surg Oncol"},{"issue":"8","key":"1536_CR7","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.jid.2022.01.025","volume":"142","author":"E Brenner","year":"2022","unstructured":"Brenner E, R\u00f6cken M. A commotion in the skin: developing melanoma immunotherapies. J Invest Dermatol. 2022;142(8):2055\u201360.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1536_CR8","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/med.21765","volume":"41","author":"H Sadeghi Rad","year":"2021","unstructured":"Sadeghi Rad H, et al. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev. 2021;41(3):1474\u201398.","journal-title":"Med Res Rev"},{"issue":"3","key":"1536_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"5","key":"1536_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cac2.12294","volume":"42","author":"H Zhou","year":"2022","unstructured":"Zhou H, et al. Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis. Cancer Commun (Lond). 2022;42(5):374\u2013400.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"1536_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1152\/physrev.00008.2020","volume":"101","author":"KF Goliwas","year":"2021","unstructured":"Goliwas KF, et al. Moving immune therapy forward targeting TME. Physiol Rev. 2021;101(2):417\u201325.","journal-title":"Physiol Rev"},{"issue":"1","key":"1536_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, et al. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29(1):83.","journal-title":"J Biomed Sci"},{"issue":"16","key":"1536_CR13","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1016\/j.jmb.2016.03.021","volume":"428","author":"GA Rabinovich","year":"2016","unstructured":"Rabinovich GA, Conejo-Garc\u00eda JR. Shaping the immune landscape in cancer by galectin-driven regulatory pathways. J Mol Biol. 2016;428(16):3266\u201381.","journal-title":"J Mol Biol"},{"issue":"3","key":"1536_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jaci.2014.11.031","volume":"135","author":"BS Bochner","year":"2015","unstructured":"Bochner BS, Zimmermann N. Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. J Allergy Clin Immunol. 2015;135(3):598\u2013608.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1536_CR15","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1172\/JCI120612","volume":"128","author":"MA Stanczak","year":"2018","unstructured":"Stanczak MA, et al. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. J Clin Invest. 2018;128(11):4912\u201323.","journal-title":"J Clin Invest"},{"issue":"1","key":"1536_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11912-022-01347-4","volume":"25","author":"JHS Wang","year":"2023","unstructured":"Wang JHS, et al. Development of effective siglec-9 antibodies against cancer. Curr Oncol Rep. 2023;25(1):41\u20139.","journal-title":"Curr Oncol Rep"},{"key":"1536_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.878849","volume":"12","author":"H Xu","year":"2022","unstructured":"Xu H, et al. High expression levels of SIGLEC9 indicate poor outcomes of glioma and correlate with immune cell infiltration. Front Oncol. 2022;12: 878849.","journal-title":"Front Oncol"},{"issue":"1","key":"1536_CR18","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","volume":"12","author":"E Rodriguez","year":"2021","unstructured":"Rodriguez E, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12(1):1270.","journal-title":"Nat Commun"},{"issue":"2","key":"1536_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/cei.13444","volume":"201","author":"L Tao","year":"2020","unstructured":"Tao L, et al. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma. Clin Exp Immunol. 2020;201(2):161\u201370.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1536_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","volume":"7","author":"Q Haas","year":"2019","unstructured":"Haas Q, et al. Siglec-9 regulates an effector memory CD8+ T-cell subset that congregates in the melanoma tumor microenvironment. Cancer Immunol Res. 2019;7(5):707\u201318.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"1536_CR21","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/jid.2012.133","volume":"132","author":"VR Wiersma","year":"2012","unstructured":"Wiersma VR, et al. The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells. J Invest Dermatol. 2012;132(9):2302\u20135.","journal-title":"J Invest Dermatol"},{"issue":"W1","key":"1536_CR22","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1536_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"21","key":"1536_CR24","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, et al. TIMER: AWeb server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"2","key":"1536_CR25","doi-asserted-by":"publisher","first-page":"e4562","DOI":"10.1002\/pro.4562","volume":"32","author":"A Digre","year":"2023","unstructured":"Digre A, Lindskog C. The Human Protein Atlas - integrated omics for single cell mapping of the human proteome. Protein Sci. 2023;32(2): e4562.","journal-title":"Protein Sci"},{"issue":"D1","key":"1536_CR26","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49(D1):D1420\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1536_CR27","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.immuni.2021.08.019","volume":"54","author":"AK Molodtsov","year":"2021","unstructured":"Molodtsov AK, et al. Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma. Immunity. 2021;54(9):2117-2132.e7.","journal-title":"Immunity"},{"key":"1536_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omto.2020.12.003","volume":"20","author":"W Deng","year":"2020","unstructured":"Deng W, et al. Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma. Mol Ther Oncolytics. 2020;20:105\u201318.","journal-title":"Mol Ther Oncolytics"},{"issue":"49","key":"1536_CR29","doi-asserted-by":"publisher","first-page":"35417","DOI":"10.1074\/jbc.M113.513192","volume":"288","author":"I Sabit","year":"2013","unstructured":"Sabit I, et al. Binding of a sialic acid-recognizing lectin siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein Degradation. J Biol Chem. 2013;288(49):35417\u201327.","journal-title":"J Biol Chem"},{"key":"1536_CR30","doi-asserted-by":"publisher","first-page":">828916","DOI":"10.3389\/fcell.2022.828916","volume":"10","author":"J Wang","year":"2022","unstructured":"Wang J, et al. Siglec receptors modulate dendritic cell activation and antigen presentation to T cells in cancer. Front Cell Dev Biol. 2022;10:828916.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"1536_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/ni.3552","volume":"17","author":"R Beatson","year":"2016","unstructured":"Beatson R, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17(11):1273\u201381.","journal-title":"Nat Immunol"},{"issue":"6","key":"1536_CR32","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00262-022-03364-5","volume":"72","author":"F Zhao","year":"2023","unstructured":"Zhao F, et al. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2023;72(6):1835\u201351.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"1536_CR33","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","volume":"12","author":"AJ Nirmal","year":"2022","unstructured":"Nirmal AJ, et al. The spatial landscape of progression and immunoediting in primary melanoma at single cell resolution. Cancer Discov. 2022;12(6):1518\u201341.","journal-title":"Cancer Discov"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01536-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:03:47Z","timestamp":1724079827000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01536-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01536-8","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data was downloaded from public databases and did not require ethical approval. However, we followed the regulations set by the public databases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}